Table 4.

Maternal disease activity by outcome for pregnancies from clinical trial reports: CD and RA subgroups*. Range of CDAI index: 0–600, remission < 150, low disease activity 150–219, moderate disease activity 220–450, and high disease activity > 450. Range of DAS28-ESR index: 0–10, remission ≤ 2.6, low disease activity > 2.6 to ≤ 3.2, moderate disease activity > 3.2 to ≤ 5.1, and high disease activity > 5.1.

CDLive Birth, n = 6Miscarriage, n = 2Induced Abortion, n = 4Total, n = 12
CDAI at baseline, CD study entry
  Mean (SD)280.3 (42.0)296.0 (7.2)320.1 (47.8)296.2 (42.1)
  Median275.4296.0304.9288.8
  Min, max223, 347291, 301284, 387223, 387
CDAI at visit prior to pregnancy report
  Mean (SD)180.5 (100.9)151.4 (2.3)168.8 (99.3)171.7 (86.2)
  Median200.3151.4163.2175.8
  Min, max34, 304150, 15372, 27734, 304
CDAI change from baseline
  Mean (SD)−99.9 (74.1)−144.6 (9.6)−151.3 (84.7)−124.5 (71.6)
  Median−86.2−144.6−147.9−123.9
  Min, max−189, 1−151, −138−251, −58−251, 1
RALive Birth, n = 7Miscarriage, n = 4Induced Abortion, n = 3Total, n = 14
DAS28-ESR at baseline, RA study entry
  Mean (SD)6.4 (0.8)6.1 (0.7)6.6 (0.9)6.4 (0.8)
  Median6.26.16.66.2
  Min, max5.1, 7.35.4, 7.05.8, 7.65.1, 7.6
DAS28-ESR at visit prior to pregnancy report
  Mean (SD)3.5 (1.7)2.4 (1.4)4.4 (1.1)3.4 (1.6)
  Median2.71.94.22.9
  Min, max2.2, 6.31.3, 4.53.4, 5.61.3, 6.3
DAS28-ESR change from baseline
  Mean (SD)−2.9 (1.6)−3.7 (1.6)−2.2 (0.8)−3.0 (1.5)
  Median−3.0−4.0−2.1−3.0
  Min, max−4.7, −0.6−5.2, −1.6−3.1, −1.6−5.2, −0.6
  • * Includes pregnancies collected between July 12, 2001 and March 28, 2013. CD: Crohn disease; RA: rheumatoid arthritis; CDAI: Crohn’s Disease Activity Index; DAS28: 28-joint Disease Activity Score; ESR: erythrocyte sedimentation rate.